Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...

The new ‘innovator passport’ will mean technology that has been robustly assessed by one NHS organisation can easily be ...

From political name-calling to social media meltdowns, public life feels more hostile than ever. But quiet acts of kindness ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...